Ikeda K, Mano-Usui F, Kishimoto Y, Yabe D, et al. Concurrent SGLT2 inhibitor use in patients with type 2 diabetes hospitalised for high-dose corticosteroid therapy: Mitigated iatrogenic hyperglycaemia. Diabetes Obes Metab 2025 Feb 3. doi: 10.1111/dom.16221.
PMID: 39895426